title: Serotonin type 3-receptor antagonists for chemotherapy-induced nausea and vomiting: therapeutically equivalent or meaningfully different?
authors.affiliation: Jill M. Kolesar, Pharm.D., BCPS, FCCP, is Professor of Pharmacy, School of Pharmacy, University of Wisconsin (UW)-Madison, and Director, 3P Analytical Laboratory, UW Carbone Comprehensive Cancer Center, Madison. Jens Eickhoff, Ph.D., is Senior Scientist, Department of Biostatistics and Medical Informatics, School of Medicine and Population Health, UW-Madison. Lee C. Vermeulen, B.S.Pharm., M.S., FCCP, is Clinical Professor, School of Pharmacy, UW-Madison, and Director, Center for Clinical Knowledge Management, UW Health, Madison.
authors.forename: Jill M
authors.initials: JM
authors.lastname: Kolesar
authors.forename: Jens
authors.initials: J
authors.lastname: Eickhoff
authors.forename: Lee C
authors.initials: LC
authors.lastname: Vermeulen
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects*; D006801:Humans; D009325:Nausea / Q000139:chemically induced / Q000188:drug therapy*; D058831:Serotonin 5-HT3 Receptor Antagonists / Q000493:pharmacokinetics / Q000627:therapeutic use*; D013810:Therapeutic Equivalency; D014839:Vomiting / Q000139:chemically induced / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D058831:Serotonin 5-HT3 Receptor Antagonists